Mistral Continuous (Dienogest, Ethinylestradiol | Lactose Anhydrous)

Dienogest is a synthetic progestogen that binds to progesterone receptors, stabilising the endometrial lining and thickening cervical mucus. Together with ethinylestradiol, it suppresses the luteinising hormone surge, thereby inhibiting ovulation and preventing fertilisation and implantation.

The dosing regimen is determined by the prescribing clinician. Typically, the product is taken as a daily tablet for a 21‑day active phase followed by a 7‑day placebo phase, but the exact schedule and any variations are set by the healthcare professional.

Mistral Continuous is contraindicated during pregnancy; if pregnancy occurs, the product should be discontinued immediately. Limited data exist for use while breastfeeding, and most clinicians advise against continued use during lactation unless the benefits outweigh potential risks.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any required temperature control) and import documentation.

Mistral Continuous uses dienogest, a newer progestogen with a lower androgenic profile compared with older agents such as levonorgestrel. This may result in a reduced risk of acne or lipid changes, while maintaining comparable contraceptive efficacy and cycle‑control benefits.

Store the tablets at ambient temperature, preferably below 25 °C. Keep them in the original blister pack, protect from moisture and direct sunlight, and discard any tablets that are discoloured or damaged.

Mistral Continuous is taken orally with a glass of water, preferably at the same time each day. The tablet should be swallowed whole; it should not be chewed, crushed, or split unless specifically instructed by a healthcare professional.

The most serious risks include venous thromboembolism, arterial thrombosis such as stroke or myocardial infarction, severe hypertension, and rare liver disorders. Patients should be educated to seek immediate medical attention for symptoms like sudden leg pain, chest pain, severe headache, or visual changes.

Women who are pregnant, have a history of thromboembolic events, are smokers over 35 years of age, have uncontrolled hypertension, active liver disease, breast cancer, or migraine with aura should avoid using Mistral Continuous. Contraindications are outlined in the prescribing information.